Global Access
How Can (Bio)pharmaceutical Companies Contribute to Improving Global Access to Essential Medications?
Pharma's Almanac
PAO-08-24-RT-02Aug 07, 2024
CDMO
Maximizing Outsourcing Benefits for Virtual Pharma Companies
William Kazimier
Tedor Pharma Services
PAO-09-23-CL-08Jan 11, 2024
CDMO
Redesigning ANDA or Novel Drug Products at All Stages for the U.S. Market
Tedor Pharma Services
PAO-08-23-CL-06Sep 26, 2023
Parenterals
Trends Shaping the Dynamic Market for Parenterals
Marga Viñes
Grifols
PAP-Q3-20-CL-018Sep 29, 2020
FDA Approval
Perrigo and Catalent Announce FDA Approval of Perrigo's AB-Rated Generic Version of ProAir® HFA
Perrigo
PR-M02-20-NI-041Feb 27, 2020
Market Prediction
Popularity of Generic Drugs Poised to Overshadow Atherosclerosis Drugs Market Growth
Transparency Market Research
PR-M01-20-NI-022Jan 15, 2020
Generics
Seqens North America Identifies Trends Affecting the Generic Drugs Sector in 2020
Seqens
PR-M01-20-NI-021Jan 15, 2020
M&A
ANI Pharmaceuticals Announces Acquisition of Commercial and Pipeline Generic Products from Amerigen Pharmaceuticals, Ltd.
ANI Pharmaceuticals, Inc.
PR-M01-20-NI-019Jan 14, 2020
Generic
Amneal Announces Approval of Generic Version of Amicar®
Amneal Pharmaceuticals Inc.
PR-M09-19-NI-024Sep 10, 2019
Generics
China Eases Generic Drug Market Shake-Up
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-M08-19-NI-001Aug 01, 2019
Generics
FDA Approves First Generics of Lyrica
U.S. Food & Drug Administration
PR-M07-19-NI-060Jul 23, 2019
FDA Approval
MSN Labs/Novadoz Pharmaceuticals Early Success Continues With FDA Approval Of Generic Abiraterone
Novadoz Pharmaceuticals
PR-M07-19-NI-045-2367Jul 17, 2019
Generics
Mallinckrodt Modifies Specialty Generics Spinout Portfolio Composition
Nice Insight
PAO-M06-19-NI-004Jun 13, 2019
Generics
Mallinckrodt Updates Plans for Company Separation and Spin-Off of Specialty Generics Business to Shareholders
Mallinckrodt Pharmaceuticals
PR-M05-19-NI-087May 31, 2019
Generics
State Lawsuit Charges Generic Makers with Price Fixing
Nice Insight
PAO-M05-19-NI-032May 29, 2019
Generics
Being at the Right Place at the Right Time
Ori Gutwerg
Taro Pharmaceutical Industries
PAP-Q2-2019-CL-033May 24, 2019
Generics
Teva Announces Launch of a Generic Version of Tarceva® (erlotinib) Tablets in the United States
Teva Pharmaceutical Industries
PR-M05-19-NI-045May 15, 2019
Generic
First Generic Nalaxone Nasal Spray Approved by FDA
Emilie Branch
Pharma's Almanac
PAO-M05-19-NI-006May 02, 2019
Generics
The Generic Pharmaceutical Market in Kenya & Nigeria - Forecast to 2022
ResearchandMarkets
PR-M04-19-NI-079Apr 25, 2019
Generics
Teva Announces Launch of a Generic Version of VESIcare® (solifenacin succinate) Tablets in the United States
Teva Pharmaceutical Industries
PR-M04-19-NI-072Apr 23, 2019